HYPR on Nasdaq

Hyperfine, Inc.

American electromedical and electrotherapeutic apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

$13.6MRevenue, fiscal 20252
-$35.6MNet income, fiscal 20252

Compare with CapsoVision, Inc, ESCALON MEDICAL CORP or QT IMAGING HOLDINGS, INC., or pick any stock.

  • TickerHYPR on Nasdaq1
  • IndustryElectromedical & Electrotherapeutic Apparatus1
  • HeadquartersGuilford, Connecticut1
  • Incorporated inDE3
  • Business address351 New Whitfield Street, Guilford, Ct 064373
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

We are an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (“AI”)-powered portable ultra-low-field (“ULF”) magnetic resonance (“MR”) brain imaging. Our Swoop® Portable MR Imaging® System (“Swoop® system”) produces high-quality images at a significantly lower magnetic field strength than conventional magnetic resonance imaging (“MRI”) scanners. Our Swoop® system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated patient-friendly experience, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop® system is a portable, ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. When in…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

49.8%Gross margin2
-273.4%Operating margin2
-262.3%Net margin2
5.2%Revenue growth, 20252
-86.8%Return on equity2
-$29.1MFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 84% of the revenue Hyperfine, Inc. broke down this way in fiscal 2025.

  1. Product$11.4M284%up 9% from 2024
  2. Service$2.2M216%down 11% from 2024
Products and services by year
Products and services20242025
Product$10.4M$11.4M
Service$2.4M$2.2M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue28¢$6.8M
  • Research and development72¢$17.5M

Out of $13.6M in revenue.2 The company lost money this year.

Financial statements

Revenue56782$13.6M in 2025+4513% since 2020
0$5.0M$10.0M$15.0M2020: $294.0K$294.0K20202021: $1.5M$1.5M2021+409%2022: $6.8M$6.8M2022+355%2023: $11.0M$11.0M2023+62%2024: $12.9M$12.9M2024+17%2025: $13.6M$13.6M2025+5%
Gross profit56782$6.8M in 2025
-$2.0M0$2.0M$4.0M$6.0M$8.0M2020: -$477.0K-$477.0K20202021: -$1.2M-$1.2M2021+145%2022: $907.0K$907.0K20222023: $4.8M$4.8M2023+424%2024: $5.9M$5.9M2024+24%2025: $6.8M$6.8M2025+15%
Operating income56782-$37.1M in 2025+58% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M02020: -$23.5M-$23.5M20202021: -$64.9M-$64.9M2021+176%2022: -$73.9M-$73.9M2022+14%2023: -$48.1M-$48.1M2023−35%2024: -$43.2M-$43.2M2024−10%2025: -$37.1M-$37.1M2025−14%
Net income5682-$35.6M in 2025+52% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M02020: -$23.4M-$23.4M20202021: -$64.9M-$64.9M2021+177%2022: -$44.2M-$44.2M2022−32%2023: -$44.2M-$44.2M2023+0%2024: -$40.7M-$40.7M2024−8%2025: -$35.6M-$35.6M2025−13%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-12-312024-12-31
Total sales$13.6M$12.9M
Total cost of sales$6.8M$7.0M
Gross profit$6.8M$5.9M
Research and development$17.5M$22.5M
General and administrative$16.3M$17.5M
Sales and marketing$10.1M$9.1M
Total operating expenses$43.8M$49.1M
Loss from operations-$37.1M-$43.2M
Interest income$1.0M$2.5M
Change in fair value of warrant liabilities$825.0K$0
Other income (expense), net-$337.0K$12.0K
Loss before provision for income taxes-$35.6M-$40.7M
Provision for income taxes$0$0
Net loss and comprehensive loss-$35.6M-$40.7M
Net loss per common share attributable to common stockholders, basic-$0.43-$0.56
Net loss per common share attributable to common stockholders, diluted-$0.43-$0.56
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic81.8M shares72.4M shares
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted81.8M shares72.4M shares

Compare Hyperfine, Inc. with another company

Leadership

Who has led Hyperfine, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Christopher Jon Gaulin2021

President

  1. George C. Petrocheilos2021

Chief financial officer

  1. Christine Clarke2021
  2. Alok Gupta2021–2023
  3. Brett Hale2025–now

Chief operating officer

  1. Thomas Teisseyre2023–now
2025
Board members and other officers (15)

Former names

  • HealthCor Catalio Acquisition Corp.Dec 9, 2020 to Dec 22, 20213

Timeline

  1. Jan 26, 2021New chief executive Christopher Jon Gaulin becomes CEO13

Filings

320 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 65 major events, 134 insider forms, 9 large holders, 92 other. The latest 20:

  1. Oct 8, 20268-K EDGAR
  2. Sep 18, 20268-K EDGAR
  3. Aug 25, 20264 EDGAR
  4. Aug 25, 20264 EDGAR
  5. Aug 6, 202610-Q EDGAR
  6. Aug 6, 20268-K EDGAR
  7. Jul 28, 2026SCHEDULE 13G EDGAR
  8. Jun 4, 20264 EDGAR
  9. May 27, 20264 EDGAR
  10. May 27, 20264 EDGAR
  11. May 22, 20264 EDGAR
  12. May 22, 20264 EDGAR
  13. May 22, 20264 EDGAR
  14. May 22, 20264 EDGAR
  15. May 21, 2026EFFECT EDGAR
  16. May 21, 20268-K EDGAR
  17. May 19, 2026CORRESP EDGAR
  18. May 18, 2026UPLOAD EDGAR
  19. May 12, 2026S-3 EDGAR
  20. May 12, 202610-Q EDGAR

The 320 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

47 open-market trades by officers, directors and large owners since October 2021: 17 buys and 30 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 24, 2026TEISSEYRE THOMASChief Operating OfficerSale7,345$0.85$6.2KForm 4
Aug 24, 2026HALE BRETTCFO and CAOSale7,345$0.85$6.2KForm 4
May 26, 2026HALE BRETTCFO and CAOSale6,047$1.65$10.0KForm 4
May 26, 2026TEISSEYRE THOMASChief Operating OfficerSale6,047$1.65$10.0KForm 4
Mar 23, 2026TEISSEYRE THOMASChief Operating OfficerSale24,188$1.21$29.3KForm 4
Mar 23, 2026HALE BRETTCFO and CAOSale24,188$1.21$29.3KForm 4
Feb 13, 2026TEISSEYRE THOMASChief Operating OfficerSale821$1.11$911Form 4
Nov 19, 2025TEISSEYRE THOMASChief Operating OfficerSale1,405$1.08$1.5KForm 4
Aug 18, 2025TEISSEYRE THOMASChief Operating OfficerSale1,151$1.33$1.5KForm 4
May 16, 2025TEISSEYRE THOMASChief Operating OfficerSale2,776$0.58$1.6KForm 4
Feb 20, 2025TEISSEYRE THOMASChief Operating OfficerSale3,238$1.08$3.5KForm 4
Feb 18, 2025TEISSEYRE THOMASChief Operating OfficerSale3,237$1.20$3.9KForm 4
Nov 18, 2024TEISSEYRE THOMASChief Operating OfficerSale2,800$0.85$2.4KForm 4
Aug 16, 2024TEISSEYRE THOMASChief Operating OfficerSale2,746$1.05$2.9KForm 4
May 16, 2024TEISSEYRE THOMASChief Operating OfficerSale2,753$0.88$2.4KForm 4
Feb 16, 2024TEISSEYRE THOMASChief Operating OfficerSale3,230$1.11$3.6KForm 4
Nov 16, 2023TEISSEYRE THOMASChief Operating OfficerSale2,655$1.26$3.3KForm 4
Aug 16, 2023TEISSEYRE THOMASChief Operating OfficerSale2,785$2.26$6.3KForm 4
Aug 16, 2023Siddiqui KhanCMO and Chief Strategy OfficerSale1,729$2.26$3.9KForm 4
May 16, 2023Siddiqui KhanCMO and Chief Strategy OfficerSale1,735$1.25$2.2KForm 4

All 47 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 81. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.4,673,087$6.3M0.0%+4,098,184
Vanguard Capital Management LLC3,380,087$4.6M0.0%−73,076
Geode Capital Management, LLC1,960,811$2.6M0.0%+1,005,551
Fosun International Ltd1,742,020$2.4M0.5%No change
Catalio Capital Management, LP1,320,041$1.8M0.3%No change
State Street Corp1,016,970$1.4M0.0%+692,900
Renaissance Technologies LLC945,836$1.3M0.0%+215,603
Alphabet Inc.898,720$1.2M0.0%No change
Northern Trust Corp633,054$854.6K0.0%+455,686
Vanguard Fiduciary Trust Co567,109$765.6K0.0%+40,403
Vanguard Portfolio Management LLC547,200$738.7K0.0%New
Marshall Wace, Llp342,116$461.9K0.0%New
Two Sigma Investments, LP325,999$440.1K0.0%New
Isthmus Partners, LLC313,350$423.0K0.0%No change
Bank of New York Mellon Corp310,405$419.0K0.0%+171,442
Gwn Securities Inc.274,677$370.8K0.1%New
Charles Schwab Investment Management Inc190,235$256.8K0.0%New
HighTower Advisors, LLC186,737$252.1K0.0%No change
Bridgeway Capital Management, LLC128,400$173.3K0.0%+8,700
Nuveen, LLC102,831$138.8K0.0%New
Cerity Partners LLC85,000$114.8K0.0%+5,000
Deutsche Bank Ag\78,220$105.6K0.0%New
Wells Fargo & Company/mn73,992$99.9K0.0%+71,411
Tortoise Investment Management, LLC72,000$97.2K0.0%No change
Centiva Capital, LP63,035$85.1K0.0%+38,087

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37